Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision.

    Halton KA, Cook DA, Whitby M, Paterson DL, Graves N.

    Crit Care. 2009;13(2):R35. Epub 2009 Mar 11.PMID: 19284570 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.

    Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A, Dündar Y, Gamble C, McLeod C, Walley T, Dickson R.

    Health Technol Assess. 2008 Apr;12(12):iii-iv, xi-xii, 1-154. Review.PMID: 18405471 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    New choices for central venous catheters: potential financial implications.

    Shorr AF, Humphreys CW, Helman DL.

    Chest. 2003 Jul;124(1):275-84.PMID: 12853534 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.

    Veenstra DL, Saint S, Sullivan SD.

    JAMA. 1999 Aug 11;282(6):554-60.PMID: 10450717 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.

    Marciante KD, Veenstra DL, Lipsky BA, Saint S.

    Am J Infect Control. 2003 Feb;31(1):1-8.PMID: 12548250 [PubMed - indexed for MEDLINE]Related articles

    6.

    A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units.

    Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, Whitby M, Graves N.

    Am J Infect Control. 2008 Mar;36(2):104-17.PMID: 18313512 [PubMed - indexed for MEDLINE]Related articles

    7.

    The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?

    Saint S, Veenstra DL, Lipsky BA.

    Infect Control Hosp Epidemiol. 2000 Jun;21(6):375-80. Review.PMID: 10879567 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.

    Schuerer DJ, Zack JE, Thomas J, Borecki IB, Sona CS, Schallom ME, Venker M, Nemeth JL, Ward MR, Verjan L, Warren DK, Fraser VJ, Mazuski JE, Boyle WA, Buchman TG, Coopersmith CM.

    Surg Infect (Larchmt). 2007 Aug;8(4):445-54.PMID: 17883361 [PubMed - indexed for MEDLINE]Related articles

    9.

    A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.

    Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R.

    Crit Care Med. 2006 Mar;34(3):668-75.PMID: 16505651 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.

    Maki DG, Stolz SM, Wheeler S, Mermel LA.

    Ann Intern Med. 1997 Aug 15;127(4):257-66.PMID: 9265424 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units.

    Alonso-Echanove J, Edwards JR, Richards MJ, Brennan P, Venezia RA, Keen J, Ashline V, Kirkland K, Chou E, Hupert M, Veeder AV, Speas J, Kaye J, Sharma K, Martin A, Moroz VD, Gaynes RP.

    Infect Control Hosp Epidemiol. 2003 Dec;24(12):916-25.PMID: 14700407 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.

    Walder B, Pittet D, Tramèr MR.

    Infect Control Hosp Epidemiol. 2002 Dec;23(12):748-56.PMID: 12517018 [PubMed - indexed for MEDLINE]Related articles

    13.

    Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater.

    Crnich CJ, Maki DG.

    Clin Infect Dis. 2004 May 1;38(9):1287-92. Epub 2004 Apr 15.PMID: 15127342 [PubMed - indexed for MEDLINE]Related articles

    14.

    Are antiseptic-coated central venous catheters effective in a real-world setting?

    Borschel DM, Chenoweth CE, Kaufman SR, Hyde KV, VanDerElzen KA, Raghunathan TE, Collins CD, Saint S.

    Am J Infect Control. 2006 Aug;34(6):388-93.PMID: 16877109 [PubMed - indexed for MEDLINE]Related articles

    15.

    Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.

    Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C.

    Ann Intern Med. 1997 Aug 15;127(4):267-74.PMID: 9265425 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation.

    Vokurka S, Kabatova-Maxova K, Skardova J, Bystricka E.

    Support Care Cancer. 2009 Feb;17(2):145-51. Epub 2008 May 1.PMID: 18449570 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review.

    Gilbert RE, Harden M.

    Curr Opin Infect Dis. 2008 Jun;21(3):235-45. Review.PMID: 18448967 [PubMed - indexed for MEDLINE]Related articles

    18.

    The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.

    Maki DG, Kluger DM, Crnich CJ.

    Mayo Clin Proc. 2006 Sep;81(9):1159-71. Review.PMID: 16970212 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Decreasing catheter-related infection and hospital costs by continuous quality improvement.

    Civetta JM, Hudson-Civetta J, Ball S.

    Crit Care Med. 1996 Oct;24(10):1660-5.PMID: 8874302 [PubMed - indexed for MEDLINE]Related articles

    20.

    Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

    Shepherd J, Jones J, Takeda A, Davidson P, Price A.

    Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article